1. A 24-week randomized, double-blind, placebo-controlled study of the efficacy and tolerability of TNFR: Fc (etanercept) in the treatment of dementia of the Alzheimer type;Bohac;Neurobiol Aging,2002
2. Etanercept in Alzheimer disease: a randomized, placebo-controlled, double-blind, Phase 2 trial;Butchart;Neurology,2015
3. Perispinal etanercept: potential as an Alzheimer therapeutic;Griffin;J Neuroinflammation,2008
4. Beneficial effects of tumour necrosis factor-alpha (TNF-alpha) blockade in rheumatoid arthritis (RA);Maini;Clin Exp Immunol,1995
5. Li et al. 2021, Etanercept reduces neuron injury and neuroinflammation via inactivating JNK and NF-κB pathways in Alzheimer’s disease: an in vitro and in vivo investigation“.